Synapse - Works

Results (3719)

Impact of enzalutamide, an androgen receptor signaling inhibitor, on time to first skeletal related event (SRE) and pain in the phase 3 AFFIRM study

Meeting Abstract

Fizazi, K.; Scher, H. I.; Saad, F.; Sternberg, C. N.; Miller, K.; Mulders, P.; Chi, K.; Basch, E.; Hirmand, M.; de Bono, J. S.
Annals of Oncology (2012)

Fulltext@MSK | Save

Detailed comparison of the safety of tivozanib versus sorafenib in patients with advanced/metastatic renal cell carcinoma (mRCC) from a phase 3 trial

Meeting Abstract

Eisen, T. Q. G.; Sternberg, C. N.; Tomczak, P.; Harza, M.; Jinga, V.; Esteves, B.; Motzer, R. J.
Annals of Oncology (2012)

Fulltext@MSK | Save

Comparative assessment of sunitinib-associated adverse events (AES) as potential biomarkers of efficacy in metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Donskov, F.; Michaelson, M. D.; Puzanov, I.; Davis, M. P.; Bjarnason, G. A.; Motzer, R. J.; Lin, X.; Cohen, D. P.; Wiltshire, R.; Rini, B. I.
Annals of Oncology (2012)

Fulltext@MSK | Save

Cabozantinib (XL184) at 40 mg in patients with metastatic castration resistant prostate cancer (mCRPC): Results of a phase 2 non-randomized expansion cohort (NRE)

Meeting Abstract

de Bono, J. S.; Smith, M. R.; Rathkopf, D.; Corn, P. G.; Mukherji, D.; Harzstark, A. L.; Sartor, O. A.; Smith, D. C.; Tunariu, N.; Sweeney, C.
Annals of Oncology (2012)

Fulltext@MSK | Save

Predicting sentinel and non-sentinel node metastases: A comparison of breast surgeons and nomograms

Meeting Abstract

De Alcantara, P. R.; Sugaya, L.; Mota, B. S.; Patil, S.; Van Zee, K. J.; Bevilacqua, J. B.
Annals of Surgical Oncology (2012)

Fulltext@MSK | Save

The analytical validation of prostate specific mRNA detection in whole blood by reverse transcription-polymerase chain reaction (RT-PCR) as a prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)